Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot suit helps stroke patients walk again sooner?

NCT ID NCT05241457

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a robotic exoskeleton called Ekso can help stroke patients improve their walking and balance during early inpatient rehabilitation. Forty adults who had a stroke were randomly assigned to receive either Ekso-assisted gait training or conventional therapy. Researchers measured walking speed, endurance, and balance to see if the robot suit offered extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ekso robotic exoskeleton
What this could lead to
If it works, this could provide a more effective way to help stroke patients regain walking ability and balance during early recovery.
What could go wrong
This is a small, early-stage trial with only 40 participants. Results may not apply to all stroke patients, and the device may not be better than standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Mar 2022

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Inpatient Rehabilitation Facility

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inpatient at Sunnyview Rehabilitation Hospital * Right or left hemispheric stroke * \>18 years of age Exclusion Criteria: * No paresis * Paraplegia * Quadriplegia * FAC of 2,3 or 4 * Weight \> 220 lbs (Ekso manufacturer criteria) * Height \> 6'4" (Ekso manufacturer criteria) * \> 3 months post stroke onset * Comorbidities affecting gait (LE fractures, Parkinson's, Severe Polyneuropathy) * LE/sacral wounds that come into contact with the Ekso * LE contractures that cannot be accommodated by Ekso * Prior Stroke * Weight Bearing Restrictions 8 * Unable to follow 1-2 step commands. * Contact precautions for COVID-19

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebrovascular accident are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sunnyview

    Schenectady, New York, 12308, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.